Soft Tissue Repair Market: Growth, Size, Share, and Trends

Report Code MD 3215
Published in Jun, 2025, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Soft Tissue Repair Market by Product (Tissue Patches, Interference Screws, Xenografts, Suture Anchors, Laparoscopic Instruments), Application (Orthopedic, Skin, Dental), End User (Hospitals, Clinics, Ambulatory Surgery Centres) - Global Forecast to 2030

 

Overview

The global soft tissue repair market, valued at US$15.12 billion in 2024, stood at US$15.96 billion in 2025 and is projected to advance at a resilient CAGR of 5.1% from 2025 to 2030, culminating in a forecasted valuation of US$20.52 billion by the end of the period. The soft tissue repair market is witnessing significant growth driven by demographic trends, technological advancements, and evolving clinical practices. Increased incidences of sports-related injuries, trauma cases, and age-related degenerative conditions are primary catalysts for the rising demand for surgical interventions in soft tissue repair. The global aging population presents elevated risks for conditions such as hernias and orthopedic injuries, amplifying the need for effective soft tissue repair solutions. Innovations in surgical techniques, the development of advanced biomaterials, and the shift towards minimally invasive procedures underpin the expansion of this market. The growing awareness among both patients and healthcare practitioners regarding the benefits of early intervention and favorable post-operative outcomes is enhancing product adoption rates. Furthermore, the expansion of healthcare infrastructure in emerging economies, coupled with escalating healthcare spending and government support, is fueling market growth. Continued advancements in tissue engineering and regenerative medicine, along with these market-enabling factors, position the soft tissue repair sector for sustained strength and development in the coming years.

Soft Tissue Repair Market– Global Forecast and Key Opportunities to 2030

Attractive Opportunities in the Soft Tissue Repair Market

Asia Pacific

The Asia Pacific soft tissue repair market will grow at the highest CAGR due to the rising incidence of traumatic injuries, growing healthcare expenditure, and the increasing awareness of advanced surgical solutions. Countries such as China, India, and South Korea have witnessed higher demand for soft tissue repair procedures owing to a rapidly expanding middle class, improving healthcare infrastructure, and increasing access to modern medical technologies

The soft tissue repair market is driven by the rising incidence of sports injuries, trauma cases, and age-related soft tissue degeneration. High demand for minimally invasive procedures and advancements in surgical technologies also fuel market growth. Additionally, increased awareness and the availability of biologics and synthetic grafts contribute to broader adoption. Expanding healthcare infrastructure and rising healthcare expenditure in emerging economies further support market expansion.

The soft tissue repair industry has undergone notable advancements and innovations, marked by the adoption of biologics, synthetic grafts, and minimally invasive surgical techniques to enhance tissue regeneration, wound healing, and post-operative outcomes

The Asia Pacific soft tissue repair market is expected to be worth USD 4.20 billion by 2030, growing at the highest CAGR of 6.1% during the forecast period.

The Asia Pacific is expected to witness the fastest growth in the soft tissue repair market due to the rising number of road accidents and trauma cases, increasing participation in sports & fitness activities, and a growing geriatric population.

Global Soft Tissue Repair Market Dynamics

DRIVER: Rising incidence of sports injuries and trauma cases

The escalating incidence of sports-related injuries, accidents, and trauma cases has been a pivotal factor in propelling the growth of the soft tissue repair market. As a greater number of individuals participate in various physical and recreational activities, the frequency of injuries such as ligament tears, tendon ruptures, and muscle strains has notably increased. This upsurge in injury cases not only highlights the importance of effective treatment options but also creates a robust demand for a wide array of soft tissue repair procedures and products. Specifically, the market has seen a rising need for surgical meshes, which are used in hernia repairs and other tissue reinforcement applications, as well as biological grafts that facilitate the regeneration of damaged ligaments and tendons. Additionally, the demand for various fixation devices, such as screws and anchors, has increased as they play a crucial role in stabilizing repaired tissues during the healing process. The growing adoption of advanced soft tissue repair treatments reflects an increasing awareness of the importance of faster and more effective recovery methods among both healthcare providers and patients. Innovations in technology and materials have led to the development of products that not only improve surgical outcomes but also enhance the overall recovery experience. Consequently, this ongoing trend contributes significantly to the expansion of the soft tissue repair market as it strives to meet the diverse clinical needs resulting from the rising prevalence of sports-related injuries and conditions.

RESTRAINT: High cost of advanced orthodontic treatment and surgical procedures

One of the significant challenges facing the soft tissue repair market is the high cost associated with advanced surgical procedures and biological materials. Treatments that utilize allografts (donor tissues from the same species), xenografts (tissues from different species), or cutting-edge tissue-engineered products often come with steep price tags. This financial burden can significantly limit accessibility for low-income or underinsured populations, forcing them to either postpone or completely avoid necessary medical interventions. As a result, many patients in these demographics may experience prolonged suffering from soft tissue injuries or conditions that could otherwise be effectively treated. This situation not only affects individual health outcomes but also contributes to the underutilization of soft tissue repair solutions, particularly in developing regions where financial resources are scarce. Moreover, the landscape is further complicated by the limited reimbursement coverage offered by various healthcare systems. Inadequate coverage can place additional financial strain on patients, discouraging them from seeking or pursuing advanced treatment options. This combination of high costs and insufficient insurance support presents a formidable barrier to the broader adoption and integration of innovative soft tissue repair technologies in clinical practice, ultimately hindering market growth and limiting the potential for improved patient care outcomes.

 

OPPORTUNITY: Growing adoption of regenerative medicine and biologics in emerging economies

The progressive adoption of regenerative medicine techniques and biologic products represents a transformative opportunity in the soft tissue repair market. Advanced interventions such as platelet-rich plasma (PRP) therapy, stem cell therapy, and bioengineered grafts are emerging as pivotal innovations due to their capacity to significantly enhance tissue healing processes, shorten recovery times, and reduce the likelihood of post-operative complications. Platelet-rich plasma therapy involves the concentration of platelets from a patient’s own blood, which are then reintroduced into the injured tissue to promote healing through the release of growth factors and cytokines. Similarly, stem cell therapy utilizes pluripotent cells that can differentiate into various tissue types, thereby facilitating repair and regeneration at a cellular level. Bioengineered grafts, often composed of scaffolding materials and cells, provide a support structure that enhances integration and promotes functional restoration of damaged tissues. These regenerative approaches are not only being increasingly recognized within the realms of sports medicine and orthopedics but are also finding applications in general surgical practices, where their ability to expedite recovery and improve patient outcomes is being evaluated through clinical trials. As evidence mounts demonstrating the efficacy of these techniques, and as both practitioners and patients become more cognizant of the potential benefits, the acceptance and utilization of regenerative therapies are set to expand within the medical community. Consequently, this trend is expected to drive growth in the soft tissue repair market, fostering further innovation and research in this promising field of medicine.

CHALLENGES: Shortage of skilled surgeons and specialized facilities

The global demand for soft tissue repair procedures, which include surgeries designed to mend damaged muscles, tendons, and ligaments, is experiencing a steady rise, driven by factors such as an aging population, increased participation in sports, and a greater prevalence of lifestyle-related injuries. However, this burgeoning demand is hindered by a significant shortage of trained surgeons and specialized surgical centers, particularly in developing regions and rural areas where healthcare infrastructure is often lacking. Complex soft tissue repair procedures, like rotator cuff repairs or anterior cruciate ligament (ACL) reconstructions, demand not only advanced surgical skills but also access to sophisticated medical facilities equipped with the necessary technology and resources. Unfortunately, in many underdeveloped areas, such infrastructure is either insufficient or entirely absent, which presents a formidable barrier to timely and effective surgical interventions. Moreover, the training required to become proficient in these intricate procedures is extensive, involving prolonged periods of education and hands-on practice. Aspiring surgeons often face limited opportunities for mentorship and specialized training programs, which can further restrict the number of qualified medical professionals entering the field. This gap in expertise not only results in delays in patient treatment but also raises concerns about the quality of care and surgical outcomes, ultimately posing a significant challenge to the overall growth of the soft tissue repair market. The combination of rising demand and constrained supply underscores the urgent need for initiatives aimed at enhancing surgical training and improving infrastructure in underserved regions.

Global Soft Tissue Repair Market Ecosystem Analysis

Soft Tissue Repair Market
 

By product, tissue patches/meshes commanded the largest market share in 2024.

Tissue patches and meshes play a crucial role in various soft tissue repair procedures, offering a multitude of advantages that have led to their widespread preference among surgeons and patients alike. One of the primary benefits of these products is their ability to provide crucial structural support, which is essential for repairing damaged tissues and facilitating effective regeneration. This is particularly evident in procedures involving hernia repair, where the reinforcement of weakened abdominal walls is necessary, as well as in the treatment of rotator cuff injuries and pelvic organ prolapse, where restoring the original function and stability of affected areas is paramount. These tissue repair products are available in two main categories: synthetic and biologic meshes. Synthetic meshes, often made from materials like polypropylene, are valued for their strength and durability. However, biologic meshes, derived from natural tissues, have been gaining popularity due to their superior biocompatibility, lower risk of infection, and reduced likelihood of rejection by the host body. This enhanced compatibility is especially critical in patients with a history of surgical complications or those who may be more prone to adverse reactions. Recent technological advancements in materials science have significantly improved the performance characteristics of both synthetic and biologic meshes. Innovations have led to the development of materials that offer enhanced strength while remaining lightweight and flexible, allowing for better integration with surrounding host tissues. This integration not only promotes faster healing but also ensures that the repair remains stable and functional over time. Moreover, the increasing prevalence of minimally invasive surgical techniques has further stimulated the demand for tissue patches and meshes. These techniques minimize tissue trauma, reduce post-operative pain, and aid in quicker recovery times, making them highly attractive options for both patients and healthcare providers. As a result, tissue patches and meshes have become a dominant segment in the medical market, reflecting their critical importance in advancing surgical outcomes and enhancing patient care.

By application, hernia repair accounted for the largest share in the soft tissue repair market in 2024.

Hernia repair represents the most significant segment of the soft tissue repair market, primarily due to the high incidence of hernias across diverse populations and the well-established protocols guiding surgical intervention. The growing adoption of mesh-based repair techniques has notably improved patient outcomes, as these methods allow for quicker recovery times and lower recurrence rates. This has, in turn, increased the demand for soft tissue repair materials. Recent advancements in surgical techniques, particularly minimally invasive and laparoscopic methods, have played a crucial role in optimizing patient recovery. These innovative approaches not only enhance the precision of the procedures but also lead to less post-operative pain, smaller incisions, and quicker discharge from the hospital. As a result, the overall length of hospital stays has been dramatically reduced, further encouraging the frequency and preference for hernia repair surgeries. Moreover, there is a heightened awareness among patients and healthcare professionals regarding the necessity of timely hernia intervention. This awareness is coupled with the expansion of healthcare access in emerging markets, making surgical options more available to a broader audience. Such factors contribute significantly to the ongoing growth and evolution within the soft tissue repair sector, highlighting the critical importance of effective hernia repair strategies in improving patient health outcomes.

 

North America held the largest share of the soft tissue repair market in 2024.

North America plays a pivotal role in the soft tissue repair market, establishing itself as the leading region largely due to its sophisticated healthcare infrastructure and the high volume of surgical procedures performed annually. This region has been at the forefront of adopting innovative medical technologies, which have significantly enhanced the effectiveness of soft tissue repair solutions. The growing incidence of various medical conditions, including hernias, sports-related injuries, and trauma that result in soft tissue damage, has intensified the need for advanced and effective repair options. These conditions often require prompt surgical intervention, thereby boosting the demand for soft tissue repair products. In addition to these factors, several elements contribute to North America's market dominance. Favorable reimbursement policies have made it financially viable for healthcare providers to utilize high-quality repair products, while the increasingly aging population is more susceptible to conditions requiring soft tissue repairs. This demographic shift is expected to propel market growth even further. Moreover, the presence of key industry players, including leading manufacturers and medical device companies, facilitates innovation and ensures a steady supply of cutting-edge products in the market. The rising awareness among both patients and clinicians regarding the benefits of minimally invasive repair techniques, which often lead to quicker recovery times and improved surgical outcomes, further promotes the extensive adoption of soft tissue repair solutions. As a result, hospitals and ambulatory surgical centers across the US and Canada are increasingly implementing these advanced repair products, thereby solidifying North America's leadership position in the global soft tissue repair market.

Soft Tissue Repair Market
US TO GROW AT HIGHEST CAGR DURING STUDY PERIOD
NORTH AMERICA FASTEST-GROWING MARKET IN THE REGION

Recent Developments of Soft Tissue Repair Market

  • In March 2024, Medtronic launched a next-generation bioabsorbable mesh for hernia repair designed to improve healing outcomes and reduce post-operative complications.
  • In January 2024, Becton, Dickinson and Company received US FDA clearance for its novel synthetic tissue patch to enhance tissue integration in soft tissue reconstruction procedures.
  • In October 2023, Johnson & Johnson’s Ethicon division launched a new range of surgical meshes featuring antimicrobial properties to reduce the risk of infection during soft tissue repair surgeries.
  • In June 2023, Smith+Nephew acquired a biotech startup specializing in regenerative tissue matrices, strengthening its soft tissue repair portfolio in sports medicine and trauma.

Key Market Players

Scope of the Report

Report Metric Details
Market size available for years 2023-2030
Base Year Considered 2024
Forecast period 2025-2030
Forecast units Value (USD Million/Billion)
Segments covered Product, Application, End user, and Region
Geographies covered North America (US and Canada), Europe (Germany, UK, France, Italy, Spain, and Rest of Europe), Asia Pacific (Japan, China, Australia, South Korea, India, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), Middle East & Africa, and GCC Countries

Frequently Asked Questions (FAQ)

What is the expected addressable market value of the soft tissue repair market over the next five years?

The soft tissue repair market is projected to reach USD 20.52 billion by 2030 from USD 15.96 billion in 2025, growing at a CAGR of 5.1% during the forecast period.

What are the key drivers for the soft tissue repair market?

The soft tissue repair market is experiencing strong growth due to several key factors, including the rising prevalence of sports injuries and the increasing geriatric population.

Which segments have been included in this report?

Product, Application, End user, and Region

What are the strategies adopted by the top market players to penetrate emerging regions?

The major players in the market use partnerships, expansions, distribution agreements, product launches, and product approvals as important growth tactics.

Who are the key players in this market?

The key players in the market are Smith & Nephew (UK), Arthrex, Inc. (US), and Stryker (US).

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Soft Tissue Repair Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
26
RESEARCH METHODOLOGY
30
EXECUTIVE SUMMARY
45
PREMIUM INSIGHTS
49
MARKET OVERVIEW
53
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Increasing geriatric population and rising prevalence of obesity
    - Increasing occurrence of sports injuries
    - Rise in R&D investments and launch of technologically advanced products
    - High volume of surgeries and advancements in regenerative technologies
    RESTRAINTS
    - Unfavorable reimbursement scenario
    - High cost of soft tissue repair products and surgical procedures
    OPPORTUNITIES
    - Growing adoption of advanced soft tissue repair products in emerging economies
    - Rising use of combination materials for enhancing product efficacy
    CHALLENGES
    - Stringent regulatory framework
    - Requirement of skilled personnel for effective use of soft tissue repair products
  • 5.3 ECOSYSTEM ANALYSIS
    ROLE IN ECOSYSTEM
  • 5.4 PRICING ANALYSIS
    AVERAGE SELLING PRICE TREND OF SYNTHETIC MESHES, BY REGION, 2022–2024
    AVERAGE SELLING PRICE FOR SOFT TISSUE REPAIR PRODUCTS, BY TYPE, 2023
    AVERAGE SELLING PRICE TREND OF SOFT TISSUE REPAIR PRODUCTS, BY KEY PLAYER, 2022–2024
  • 5.5 SUPPLY CHAIN ANALYSIS
  • 5.6 PATENT ANALYSIS
    PATENT PUBLICATION TRENDS FOR SOFT TISSUE REPAIR MARKET
    TOP APPLICANTS (COMPANIES) OF SOFT TISSUE REPAIR PATENTS
    JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN SOFT TISSUE REPAIR MARKET
    LIST OF MAJOR PATENTS
  • 5.7 VALUE CHAIN ANALYSIS
  • 5.8 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Stem cell and regenerative therapies
    - Suture anchors and fixation devices
    ADJACENT TECHNOLOGIES
    - 3D bioprinting and tissue engineering
    - Regenerative medicine and biologics
    COMPLEMENTARY TECHNOLOGIES
    - Wound closure and hemostatic devices
  • 5.9 TRADE ANALYSIS
    IMPORT DATA FOR HS CODE 300640, 2019–2023
    EXPORT DATA FOR HS CODE 300640, 2019–2023
  • 5.10 KEY CONFERENCES & EVENTS, 2025–2026
  • 5.11 REGULATORY ANALYSIS
    REGULATORY FRAMEWORK
    - North America
    - Europe
    - Asia Pacific
    - Latin America
    - Middle East
    - Africa
    REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS
  • 5.12 PORTER’S FIVE FORCES ANALYSIS
    THREAT OF NEW ENTRANTS
    INTENSITY OF COMPETITIVE RIVALRY
    BARGAINING POWER OF BUYERS
    BARGAINING POWER OF SUPPLIERS
    THREAT OF SUBSTITUTES
  • 5.13 KEY STAKEHOLDERS & BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    KEY BUYING CRITERIA
  • 5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
  • 5.15 CASE STUDY ANALYSIS
    TREATMENT OF CHRONIC SHOULDER INSTABILITY USING REGENETEN BIOINDUCTIVE IMPLANTS
    TREATMENT OF INCISIONAL HERNIA USING PARIETEX COMPOSITE VENTRAL PATCHES BY MEDTRONIC
    HEALING CHRONIC DIABETIC FOOT ULCERS WITH BILAYER WOUND MATRIX
  • 5.16 INVESTMENT & FUNDING SCENARIO
  • 5.17 REIMBURSEMENT SCENARIO ANALYSIS
  • 5.18 END-USER EXPECTATIONS
  • 5.19 IMPACT OF AI/GEN AI ON SOFT TISSUE REPAIR MARKET
  • 5.20 IMPACT OF 2025 US TARIFF ON SOFT TISSUE REPAIR MARKET
    INTRODUCTION
    KEY TARIFF RATES
    PRICE IMPACT ANALYSIS
    IMPACT ON END-USE INDUSTRIES
SOFT TISSUE REPAIR MARKET, BY PRODUCT
90
  • 6.1 INTRODUCTION
  • 6.2 TISSUE PATCHES/MESHES
    SYNTHETIC MESHES
    - Cost-effectiveness and minimal risk of donor-to-host infectious disease transmission to aid market growth
    BIOLOGICAL MESHES
    - Allografts
    - Xenografts
    FIXATION PRODUCTS
    - Suture anchors
    - Interference screws
    - Other fixation products
  • 6.3 LAPAROSCOPIC INSTRUMENTS
    QUICKER RECOVERY TIME, DECREASED PAIN, LOWER INFECTION RATES, AND REDUCED DISEASE RECURRENCE TO DRIVE MARKET
  • 6.4 OTHER PRODUCTS
SOFT TISSUE REPAIR MARKET, BY APPLICATION
106
  • 7.1 INTRODUCTION
  • 7.2 HERNIA REPAIR
    RISING ADOPTION OF TENSION-FREE HERNIA REPAIR PROCEDURES TO FUEL MARKET GROWTH
  • 7.3 SKIN REPAIR
    RISING CASES OF BURN INJURIES TO SUPPORT MARKET GROWTH
  • 7.4 ORTHOPEDIC SOFT TISSUE REPAIR
    INCREASING SPORTS INJURIES AMONG ATHLETES AND RISING INCIDENCE OF ARTHRITIS IN ELDERLY TO FAVOR MARKET GROWTH
  • 7.5 DENTAL SOFT TISSUE REPAIR
    RISING NUMBER OF PREVENTIVE AND COSMETIC DENTAL PROCEDURES TO PROPEL MARKET GROWTH
  • 7.6 BREAST RECONSTRUCTION
    PREVALENCE OF BREAST CANCER AND INCREASING PATIENTS UNDERGOING MASTECTOMY TO AUGMENT MARKET GROWTH
  • 7.7 DURAL REPAIR
    RISING PREVALENCE OF NEUROVASCULAR DISORDERS TO DRIVE MARKET
  • 7.8 VAGINAL SLINGS
    INCREASED OCCURRENCE OF STRESS-INDUCED URINARY INCONTINENCE (SUI) TO BOOST MARKET GROWTH
  • 7.9 OTHER APPLICATIONS
SOFT TISSUE REPAIR MARKET, BY END USER
118
  • 8.1 INTRODUCTION
  • 8.2 HOSPITALS & CLINICS
    RISING NUMBER OF REIMBURSED IN-PATIENT PROCEDURES TO DRIVE MARKET
  • 8.3 AMBULATORY SURGICAL CENTERS
    QUICKER CONSULTATION SERVICES AND MINIMAL PATIENT STAY TO FUEL MARKET GROWTH
  • 8.4 OTHER END USERS
SOFT TISSUE REPAIR MARKET, BY REGION
123
  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    US
    - US to dominate North American soft tissue repair market during forecast period
    CANADA
    - High healthcare expenditure and favorable public & private funding to support market growth
  • 9.3 EUROPE
    MACROECONOMIC OUTLOOK FOR EUROPE
    GERMANY
    - Advanced healthcare infrastructure and favorable surgical reimbursement to propel market growth
    FRANCE
    - Well-established healthcare system and high geriatric population to boost market growth
    UK
    - Increasing hernia repair and cardiovascular surgeries to stimulate market growth
    ITALY
    - Favorable government initiatives and high demand for surgical interventions to support market growth
    SPAIN
    - Increasing healthcare budget and rising focus on local medical product manufacturing to drive market
    REST OF EUROPE
  • 9.4 ASIA PACIFIC
    MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    JAPAN
    - Strong healthcare system and high geriatric population to favor market growth
    CHINA
    - Increasing number of hospitals and rising focus on healthcare policy reforms to stimulate market growth
    INDIA
    - Greater healthcare awareness and increased government support to aid market growth
    AUSTRALIA
    - Increasing government support and rising healthcare expenditure to support market growth
    SOUTH KOREA
    - Advanced healthcare infrastructure and adoption of minimally invasive surgical technologies to fuel market growth
    REST OF ASIA PACIFIC
  • 9.5 LATIN AMERICA
    MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    BRAZIL
    - Strong public healthcare system and favorable government-led initiatives to aid market growth
    MEXICO
    - Increased focus on healthcare modernization and surgical innovation to favor market growth
    REST OF LATIN AMERICA
  • 9.6 MIDDLE EAST & AFRICA
    ADVANCED HEALTHCARE INFRASTRUCTURE AND FAVORABLE GOVERNMENT POLICIES TO DRIVE MARKET
    MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 9.7 GCC COUNTRIES
    FOCUS ON MEDICAL TOURISM AND AVAILABILITY OF ADVANCED SURGICAL PROCEDURES TO AID MARKET GROWTH
    MACROECONOMIC OUTLOOK FOR GCC COUNTRIES
COMPETITIVE LANDSCAPE
194
  • 10.1 INTRODUCTION
  • 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN SOFT TISSUE REPAIR MARKET
  • 10.3 REVENUE ANALYSIS, 2020–2024
  • 10.4 MARKET SHARE ANALYSIS, 2024
  • 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2024
    - Company footprint
    - Region footprint
    - Product footprint
    - Application footprint
    - End-user footprint
  • 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
    - Detailed list of key startups/SMEs
    - Competitive benchmarking of startups/SMEs
  • 10.7 COMPANY VALUATION & FINANCIAL METRICS
    FINANCIAL METRICS
    COMPANY VALUATION
  • 10.8 R&D EXPENDITURE
  • 10.9 BRAND/PRODUCT COMPARISON
  • 10.10 COMPETITIVE SCENARIO
    PRODUCT LAUNCHES
    DEALS
    EXPANSIONS
COMPANY PROFILES
215
  • 11.1 KEY PLAYERS
    ARTHREX, INC.
    - Business overview
    - Products offered
    - MnM view
    SMITH & NEPHEW PLC
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    JOHNSON & JOHNSON SERVICES, INC.
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    BECTON, DICKINSON AND COMPANY (BD)
    - Business overview
    - Products offered
    - MnM view
    STRYKER
    - Business overview
    - Products offered
    - MnM view
    MEDTRONIC
    - Business overview
    - Products offered
    - Recent developments
    ZIMMER BIOMET
    - Business overview
    - Products offered
    - Recent developments
    INTEGRA LIFESCIENCES CORPORATION
    - Business overview
    - Products offered
    ARTIVION, INC.
    - Business overview
    - Products offered
    ORGANOGENESIS INC.
    - Business overview
    - Products offered
    LIFENET HEALTH
    - Business overview
    - Products offered
    BAXTER
    - Business overview
    - Products offered
    TISSUE REGENIX
    - Business overview
    - Products offered
    CONMED CORPORATION
    - Business overview
    - Products offered
    MERIL LIFE SCIENCES PVT. LTD.
    - Business overview
    - Products offered
    RTI SURGICAL
    - Business overview
    - Products offered
  • 11.2 OTHER PLAYERS
    SAMYANG HOLDINGS CORPORATION
    AROA BIOSURGERY LIMITED
    ACERA SURGICAL INC.
    ORTHOCELL LTD.
    ACELL, INC.
    BIOCER ENTWICKLUNGS-GMBH
    ISTO BIOLOGICS
    BETATECH MEDICAL
    MIMEDX GROUP, INC.
APPENDIX
268
  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 SOFT TISSUE REPAIR MARKET: INCLUSIONS & EXCLUSIONS
  • TABLE 2 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
  • TABLE 3 SOFT TISSUE REPAIR MARKET: RISK ANALYSIS
  • TABLE 4 SOFT TISSUE REPAIR MARKET: STUDY ASSUMPTIONS
  • TABLE 5 UK: INCREASE IN NUMBER OF CARDIAC SURGICAL PROCEDURES PERFORMED
  • TABLE 6 US VS. INDIA: COST OF SURGICAL PROCEDURES, 2023 (USD)
  • TABLE 7 SOFT TISSUE REPAIR MARKET: ROLE IN ECOSYSTEM
  • TABLE 8 AVERAGE SELLING PRICE TREND OF SYNTHETIC MESHES, BY REGION, 2022–2024 (USD)
  • TABLE 9 AVERAGE SELLING PRICE FOR SOFT TISSUE REPAIR PRODUCTS, BY TYPE, 2023
  • TABLE 10 AVERAGE SELLING PRICE OF SOFT TISSUE REPAIR PRODUCTS, BY KEY PLAYER, 2022–2024 (USD)
  • TABLE 11 SOFT TISSUE REPAIR MARKET: LIST OF MAJOR PATENTS
  • TABLE 12 IMPORT DATA FOR HS CODE 300640, BY COUNTRY, 2019–2023 (USD THOUSAND)
  • TABLE 13 EXPORT DATA FOR HS CODE 300640, BY COUNTRY, 2019–2023 (USD THOUSAND)
  • TABLE 14 SOFT TISSUE REPAIR MARKET: LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025–DECEMBER 2026
  • TABLE 15 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 17 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 18 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 19 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 20 SOFT TISSUE REPAIR MARKET: PORTER’S FIVE FORCES
  • TABLE 21 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS (%)
  • TABLE 22 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS
  • TABLE 23 CASE STUDY 1: TREATMENT OF CHRONIC SHOULDER INSTABILITY USING REGENETEN BIOINDUCTIVE IMPLANTS
  • TABLE 24 CASE STUDY 2: TREATMENT OF INCISIONAL HERNIA USING PARIETEX COMPOSITE VENTRAL PATCHES BY MEDTRONIC
  • TABLE 25 CASE STUDY 3: HEALING CHRONIC DIABETIC FOOT ULCERS WITH BILAYER WOUND MATRIX
  • TABLE 26 SOFT TISSUE REPAIR MARKET: END-USER EXPECTATIONS
  • TABLE 27 IMPACT OF AI/GEN AI ON SOFT TISSUE REPAIR MARKET
  • TABLE 28 US-ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 29 SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 30 SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 31 SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 32 SYNTHETIC MESHES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 33 SYNTHETIC MESHES MARKET, BY REGION, 2023–2030 (THOUSAND UNITS)
  • TABLE 34 BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 35 BIOLOGICAL MESHES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 36 BIOLOGICAL MESHES MARKET, BY REGION, 2023–2030 (THOUSAND UNITS)
  • TABLE 37 ALLOGRAFTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 38 XENOGRAFTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 39 FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 40 FIXATION PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 41 SUTURE ANCHORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 42 INTERFERENCE SCREWS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 43 OTHER FIXATION PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 44 SOFT TISSUE REPAIR MARKET FOR LAPAROSCOPIC INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 45 SOFT TISSUE REPAIR MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 46 SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 47 HERNIA REPAIR MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 48 SKIN REPAIR MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 49 ORTHOPEDIC SOFT TISSUE REPAIR MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 50 DENTAL SOFT TISSUE REPAIR MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 51 BREAST RECONSTRUCTION MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 52 DURAL REPAIR MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 53 VAGINAL SLINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 54 OTHER APPLICATIONS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 55 SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 56 SOFT TISSUE REPAIR MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 57 SOFT TISSUE REPAIR MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 58 SOFT TISSUE REPAIR MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 59 SOFT TISSUE REPAIR MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 60 NORTH AMERICA: SOFT TISSUE REPAIR MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 61 NORTH AMERICA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 62 NORTH AMERICA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 63 NORTH AMERICA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 64 NORTH AMERICA: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 65 NORTH AMERICA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 66 NORTH AMERICA: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 67 US: KEY MACROINDICATORS
  • TABLE 68 US: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 69 US: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 70 US: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 71 US: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 72 US: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 73 US: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 74 CANADA: KEY MACROINDICATORS
  • TABLE 75 CANADA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 76 CANADA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 77 CANADA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 78 CANADA: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 79 CANADA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 80 CANADA: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 81 EUROPE: SOFT TISSUE REPAIR MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 82 EUROPE: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 83 EUROPE: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 84 EUROPE: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 85 EUROPE: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 86 EUROPE: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 87 EUROPE: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 88 GERMANY: KEY MACROINDICATORS
  • TABLE 89 GERMANY: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 90 GERMANY: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 91 GERMANY: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 92 GERMANY: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 93 GERMANY: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 94 GERMANY: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 95 FRANCE: KEY MACROINDICATORS
  • TABLE 96 FRANCE: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 97 FRANCE: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 98 FRANCE: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 99 FRANCE: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 100 FRANCE: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 101 FRANCE: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 102 UK: KEY MACROINDICATORS
  • TABLE 103 UK: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 104 UK: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 105 UK: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 106 UK: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 107 UK: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 108 UK: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 109 ITALY: KEY MACROINDICATORS
  • TABLE 110 ITALY: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 111 ITALY: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 112 ITALY: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 113 ITALY: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 114 ITALY: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 115 ITALY: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 116 SPAIN: KEY MACROINDICATORS
  • TABLE 117 SPAIN: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 118 SPAIN: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 119 SPAIN: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 120 SPAIN: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 121 SPAIN: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 122 SPAIN: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 123 REST OF EUROPE: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 124 REST OF EUROPE: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 125 REST OF EUROPE: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 126 REST OF EUROPE: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 127 REST OF EUROPE: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 128 REST OF EUROPE: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 129 ASIA PACIFIC: SOFT TISSUE REPAIR MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 130 ASIA PACIFIC: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 131 ASIA PACIFIC: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 132 ASIA PACIFIC: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 133 ASIA PACIFIC: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 134 ASIA PACIFIC: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 135 ASIA PACIFIC: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 136 JAPAN: KEY MACROINDICATORS
  • TABLE 137 JAPAN: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 138 JAPAN: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 139 JAPAN: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 140 JAPAN: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 141 JAPAN: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 142 JAPAN: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 143 CHINA: KEY MACROINDICATORS
  • TABLE 144 CHINA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 145 CHINA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 146 CHINA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 147 CHINA: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 148 CHINA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 149 CHINA: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 150 INDIA: KEY MACROINDICATORS
  • TABLE 151 INDIA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 152 INDIA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 153 INDIA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 154 INDIA: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 155 INDIA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 156 INDIA: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 157 AUSTRALIA: KEY MACROINDICATORS
  • TABLE 158 AUSTRALIA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 159 AUSTRALIA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 160 AUSTRALIA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 161 AUSTRALIA: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 162 AUSTRALIA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 163 AUSTRALIA: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 164 SOUTH KOREA: KEY MACROINDICATORS
  • TABLE 165 SOUTH KOREA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 166 SOUTH KOREA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 167 SOUTH KOREA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 168 SOUTH KOREA: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 169 SOUTH KOREA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 170 SOUTH KOREA: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 171 REST OF ASIA PACIFIC: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 172 REST OF ASIA PACIFIC: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 173 REST OF ASIA PACIFIC: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 174 REST OF ASIA PACIFIC: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 175 REST OF ASIA PACIFIC: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 176 REST OF ASIA PACIFIC: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 177 LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 178 LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 179 LATIN AMERICA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 180 LATIN AMERICA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 181 LATIN AMERICA: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 182 LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 183 LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 184 BRAZIL: KEY MACROINDICATORS
  • TABLE 185 BRAZIL: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 186 BRAZIL: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 187 BRAZIL: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 188 BRAZIL: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 189 BRAZIL: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 190 BRAZIL: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 191 MEXICO: KEY MACROINDICATORS
  • TABLE 192 MEXICO: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 193 MEXICO: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 194 MEXICO: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 195 MEXICO: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 196 MEXICO: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 197 MEXICO: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 198 REST OF LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 199 REST OF LATIN AMERICA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 200 REST OF LATIN AMERICA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 201 REST OF LATIN AMERICA: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 202 REST OF LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 203 REST OF LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 204 MIDDLE EAST & AFRICA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 205 MIDDLE EAST & AFRICA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 206 MIDDLE EAST & AFRICA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 207 MIDDLE EAST & AFRICA: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 208 MIDDLE EAST & AFRICA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 209 MIDDLE EAST & AFRICA: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 210 GCC COUNTRIES: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 211 GCC COUNTRIES: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 212 GCC COUNTRIES: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 213 GCC COUNTRIES: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 214 GCC COUNTRIES: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 215 GCC COUNTRIES: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 216 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN SOFT TISSUE REPAIR MARKET
  • TABLE 217 SOFT TISSUE REPAIR MARKET: DEGREE OF COMPETITION
  • TABLE 218 SOFT TISSUE REPAIR MARKET: REGION FOOTPRINT
  • TABLE 219 SOFT TISSUE REPAIR MARKET: PRODUCT FOOTPRINT
  • TABLE 220 SOFT TISSUE REPAIR MARKET: APPLICATION FOOTPRINT
  • TABLE 221 SOFT TISSUE REPAIR MARKET: END-USER FOOTPRINT
  • TABLE 222 SOFT TISSUE REPAIR MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS
  • TABLE 223 SOFT TISSUE REPAIR MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SME PLAYERS, BY PRODUCT AND REGION
  • TABLE 224 SOFT TISSUE REPAIR MARKET: PRODUCT LAUNCHES, JANUARY 2022–APRIL 2025
  • TABLE 225 SOFT TISSUE REPAIR MARKET: DEALS, JANUARY 2022–APRIL 2025
  • TABLE 226 SOFT TISSUE REPAIR MARKET: EXPANSIONS, JANUARY 2022–APRIL 2025
  • TABLE 227 ARTHREX, INC.: COMPANY OVERVIEW
  • TABLE 228 ARTHREX, INC.: PRODUCTS OFFERED
  • TABLE 229 SMITH & NEPHEW PLC: COMPANY OVERVIEW
  • TABLE 230 SMITH & NEPHEW PLC: PRODUCTS OFFERED
  • TABLE 231 SMITH & NEPHEW PLC: PRODUCT LAUNCHES, JANUARY 2022–APRIL 2025
  • TABLE 232 SMITH & NEPHEW PLC: DEALS, JANUARY 2022–APRIL 2025
  • TABLE 233 SMITH & NEPHEW PLC: EXPANSIONS, JANUARY 2022–APRIL 2025
  • TABLE 234 JOHNSON & JOHNSON SERVICES, INC.: COMPANY OVERVIEW
  • TABLE 235 JOHNSON & JOHNSON SERVICES, INC.: PRODUCTS OFFERED
  • TABLE 236 JOHNSON & JOHNSON SERVICES, INC.: DEALS, JANUARY 2022–APRIL 2025
  • TABLE 237 BECTON, DICKINSON AND COMPANY (BD): COMPANY OVERVIEW
  • TABLE 238 BECTON, DICKINSON AND COMPANY (BD): PRODUCTS OFFERED
  • TABLE 239 STRYKER: COMPANY OVERVIEW
  • TABLE 240 STRYKER: PRODUCTS OFFERED
  • TABLE 241 MEDTRONIC: COMPANY OVERVIEW
  • TABLE 242 MEDTRONIC: PRODUCTS OFFERED
  • TABLE 243 MEDTRONIC: DEALS, JANUARY 2022–APRIL 2025
  • TABLE 244 MEDTRONIC: EXPANSIONS: JANUARY 2022–APRIL 2025
  • TABLE 245 MEDTRONIC: OTHER DEVELOPMENTS: JANUARY 2022–APRIL 2025
  • TABLE 246 ZIMMER BIOMET: COMPANY OVERVIEW
  • TABLE 247 ZIMMER BIOMET: PRODUCTS OFFERED
  • TABLE 248 ZIMMER BIOMET: DEALS, JANUARY 2022–APRIL 2025
  • TABLE 249 INTEGRA LIFESCIENCES CORPORATION: COMPANY OVERVIEW
  • TABLE 250 INTEGRA LIFESCIENCES CORPORATION: PRODUCTS OFFERED
  • TABLE 251 ARTIVION, INC.: COMPANY OVERVIEW
  • TABLE 252 ARTIVION, INC.: PRODUCTS OFFERED
  • TABLE 253 ORGANOGENESIS INC.: COMPANY OVERVIEW
  • TABLE 254 ORGANOGENESIS INC.: PRODUCTS OFFERED
  • TABLE 255 LIFENET HEALTH: COMPANY OVERVIEW
  • TABLE 256 LIFENET HEALTH: PRODUCTS OFFERED
  • TABLE 257 BAXTER: COMPANY OVERVIEW
  • TABLE 258 BAXTER: PRODUCTS OFFERED
  • TABLE 259 TISSUE REGENIX: COMPANY OVERVIEW
  • TABLE 260 TISSUE REGENIX: PRODUCTS OFFERED
  • TABLE 261 CONMED CORPORATION: COMPANY OVERVIEW
  • TABLE 262 CONMED CORPORATION: PRODUCTS OFFERED
  • TABLE 263 MERIL LIFE SCIENCES PVT. LTD.: COMPANY OVERVIEW
  • TABLE 264 MERIL LIFE SCIENCES PVT. LTD.: PRODUCTS OFFERED
  • TABLE 265 RTI SURGICAL: COMPANY OVERVIEW
  • TABLE 266 RTI SURGICAL: PRODUCTS OFFERED
  • TABLE 267 SAMYANG HOLDINGS CORPORATION: COMPANY OVERVIEW
  • TABLE 268 AROA BIOSURGERY LIMITED: COMPANY OVERVIEW
  • TABLE 269 ACERA SURGICAL INC.: COMPANY OVERVIEW
  • TABLE 270 ORTHOCELL LTD.: COMPANY OVERVIEW
  • TABLE 271 ACELL, INC.: COMPANY OVERVIEW
  • TABLE 272 BIOCER ENTWICKLUNGS-GMBH: COMPANY OVERVIEW
  • TABLE 273 ISTO BIOLOGICS: COMPANY OVERVIEW
  • TABLE 274 BETATECH MEDICAL: COMPANY OVERVIEW
  • TABLE 275 MIMEDX GROUP, INC.: COMPANY OVERVIEW
LIST OF FIGURES
 
  • FIGURE 1 SOFT TISSUE REPAIR MARKET SEGMENTATION & REGIONAL SCOPE
  • FIGURE 2 SOFT TISSUE REPAIR MARKET: YEARS CONSIDERED
  • FIGURE 3 SOFT TISSUE REPAIR MARKET: RESEARCH DESIGN
  • FIGURE 4 SOFT TISSUE REPAIR MARKET: KEY DATA FROM SECONDARY SOURCES
  • FIGURE 5 SOFT TISSUE REPAIR MARKET: KEY PRIMARY SOURCES (DEMAND AND SUPPLY SIDE)
  • FIGURE 6 SOFT TISSUE REPAIR MARKET: KEY DATA FROM PRIMARY SOURCES
  • FIGURE 7 SOFT TISSUE REPAIR MARKET: KEY INSIGHTS FROM INDUSTRY EXPERTS
  • FIGURE 8 BREAKDOWN OF PRIMARIES (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 9 BREAKDOWN OF PRIMARIES (DEMAND SIDE): BY END USER TYPE, DESIGNATION, AND REGION
  • FIGURE 10 SOFT TISSUE REPAIR MARKET: MARKET SIZE ESTIMATION
  • FIGURE 11 SOFT TISSUE REPAIR MARKET: REVENUE SHARE ANALYSIS (SUPPLY SIDE) (2024)
  • FIGURE 12 SOFT TISSUE REPAIR MARKET: REVENUE SHARE ANALYSIS (BOTTOM-UP APPROACH) (2024)
  • FIGURE 13 SOFT TISSUE REPAIR MARKET: TOP-DOWN APPROACH
  • FIGURE 14 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN SOFT TISSUE REPAIR MARKET
  • FIGURE 15 SOFT TISSUE REPAIR MARKET: CAGR PROJECTIONS (SUPPLY SIDE) (2024)
  • FIGURE 16 SOFT TISSUE REPAIR MARKET: DATA TRIANGULATION
  • FIGURE 17 SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION)
  • FIGURE 18 SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
  • FIGURE 19 SOFT TISSUE REPAIR MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
  • FIGURE 20 REGIONAL SNAPSHOT OF SOFT TISSUE REPAIR MARKET
  • FIGURE 21 INCREASING NUMBER OF HERNIA REPAIR SURGERIES AND RISING R&D INVESTMENTS TO DRIVE MARKET
  • FIGURE 22 ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 23 JAPAN AND TISSUE PATCHES/MESHES COMMANDED LARGEST MARKET SHARE IN 2024
  • FIGURE 24 CANADA TO REGISTER HIGHEST GROWTH RATE FROM 2025 TO 2030
  • FIGURE 25 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING STUDY PERIOD
  • FIGURE 26 SOFT TISSUE REPAIR MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 27 SOFT TISSUE REPAIR MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 28 SOFT TISSUE REPAIR MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 29 TOP PATENT APPLICANTS/OWNERS (COMPANIES/INSTITUTES) FOR SOFT TISSUE REPAIR (JANUARY 2014–APRIL 2025)
  • FIGURE 30 JURISDICTION ANALYSIS: TOP APPLICANT (COUNTRIES) FOR SOFT TISSUE REPAIR PATENTS, 2014–2025
  • FIGURE 31 SOFT TISSUE REPAIR MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 32 SOFT TISSUE REPAIR MARKET: PORTER’S FIVE FORCES ANALYSIS
  • FIGURE 33 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS
  • FIGURE 34 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS
  • FIGURE 35 SOFT TISSUE REPAIR MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
  • FIGURE 36 SOFT TISSUE REPAIR MARKET: FUNDING AND NUMBER OF DEALS, 2021–2024
  • FIGURE 37 SOFT TISSUE REPAIR MARKET: IMPACT OF AI/GEN AI
  • FIGURE 38 CANADA TO REGISTER HIGHEST CAGR DURING STUDY PERIOD
  • FIGURE 39 NORTH AMERICA: SOFT TISSUE REPAIR MARKET SNAPSHOT
  • FIGURE 40 ASIA PACIFIC: SOFT TISSUE REPAIR MARKET SNAPSHOT
  • FIGURE 41 REVENUE ANALYSIS OF KEY PLAYERS IN SOFT TISSUE REPAIR MARKET, 2020–2024
  • FIGURE 42 MARKET SHARE ANALYSIS OF KEY PLAYERS IN SOFT TISSUE REPAIR MARKET (2024)
  • FIGURE 43 SOFT TISSUE REPAIR MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
  • FIGURE 44 SOFT TISSUE REPAIR MARKET: COMPANY FOOTPRINT
  • FIGURE 45 SOFT TISSUE REPAIR MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
  • FIGURE 46 EV/EBITDA OF KEY VENDORS
  • FIGURE 47 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 48 SOFT TISSUE REPAIR MARKET: R&D EXPENDITURE OF KEY PLAYERS (2023 VS. 2024)
  • FIGURE 49 SOFT TISSUE REPAIR MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 50 SMITH & NEPHEW PLC: COMPANY SNAPSHOT
  • FIGURE 51 JOHNSON & JOHNSON SERVICES, INC.: COMPANY SNAPSHOT
  • FIGURE 52 BECTON, DICKINSON AND COMPANY (BD): COMPANY SNAPSHOT
  • FIGURE 53 STRYKER: COMPANY SNAPSHOT
  • FIGURE 54 MEDTRONIC: COMPANY SNAPSHOT
  • FIGURE 55 ZIMMER BIOMET: COMPANY SNAPSHOT
  • FIGURE 56 INTEGRA LIFESCIENCES CORPORATION: COMPANY SNAPSHOT
  • FIGURE 57 ARTIVION, INC.: COMPANY SNAPSHOT
  • FIGURE 58 ORGANOGENESIS INC.: COMPANY SNAPSHOT
  • FIGURE 59 BAXTER: COMPANY SNAPSHOT
  • FIGURE 60 TISSUE REGENIX: COMPANY SNAPSHOT
  • FIGURE 61 CONMED CORPORATION: COMPANY SNAPSHOT

 

The study involved four major activities to estimate the current size of the soft tissue repair market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

Secondary Research

In the secondary research process, various sources were utilized to identify and gather information for the study of the soft tissue repair market. These sources included company annual reports, press releases, and investor presentations, as well as white papers, certified publications, and articles by recognized authors. Reputable websites, regulatory bodies, and databases such as D&B Hoovers, Bloomberg Business, and Factiva were also consulted for this report. This research aimed to gather crucial information about the leading companies in the industry, market classification, and segmentation based on industry trends down to the most detailed levels, including geographic markets. Additionally, key developments related to the market were also focused on. Through this secondary research, a database of key industry leaders was created.

Primary Research

Extensive primary research was conducted after gathering information about the soft tissue repair market through secondary research. Several primary interviews were held with market experts from both the demand and supply sides across major regions, including North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. Data was collected through questionnaires, emails, and telephone interviews. The primary sources from the supply side included various industry experts, such as CEOs, VPs, Directors of business development, marketing, product development/innovation teams, and other key executives from manufacturers and distributors operating in the soft tissue repair market, as well as key opinion leaders.

Primary interviews were conducted to gather valuable insights, including market statistics, revenue data from products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. This primary research also provided an understanding of various trends related to technologies, applications, industry verticals, and regions. Stakeholders, including customers and end users, were interviewed to gain the buyers' perspective on suppliers, the products themselves, their current usage, and the future outlook of their businesses. This information is crucial as it impacts the overall market dynamics.

The following is a breakdown of the primary respondents:

Soft Tissue Repair Market

Note 1: C-level executives include CEOs, COOs, CTOs, and VPs.

Note 2: Others include sales, marketing, and product managers.

Note 3: Companies are classified into tiers based on their total revenue. As of 2024: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3 = < USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The research methodology used to estimate the size of the soft tissue repair market includes the following details.

The market sizing was undertaken from the global side.

Country-level Analysis: The size of the soft tissue repair market was obtained from the annual presentations of leading players and secondary data available in the public domain. Shares of products in the overall soft tissue repair market were obtained from secondary data and validated by primary participants to arrive at the total soft tissue repair market. Primary participants further validated the numbers.

Geographic Market Assessment (By Region & Country): The geographic assessment was done using the following approaches:

Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends

Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)

At each point, the assumptions and approaches were validated by industry experts who were contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall soft tissue repair market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.

Global Soft Tissue Repair Market Size: Bottom-up & Top-down Approach

Soft Tissue Repair Market

Data Triangulation

The market was split into several segments and subsegments after arriving at the overall market size—using the market size estimation processes. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment. The data was triangulated by studying various factors and trends from both the demand and supply sides in the soft tissue repair market.

Market Definition

Soft tissues within the human body include a diverse array of structures, such as muscles, tendons, ligaments, fascia, nerves, fibrous tissues, blood vessels, and synovial membranes. These tissues serve critical functions by connecting, supporting, and enveloping various organs and systems throughout the body. Soft tissue injuries arise from factors such as repetitive overuse, sprains, and strains, resulting in damage that can manifest as pain, swelling, bruising, and a decrease in functionality. Such injuries may significantly impair mobility and overall quality of life, thus requiring comprehensive management approaches. The surgical procedure known as soft tissue repair is designed to restore and reinforce damaged, weakened, or ruptured soft tissues. This intervention employs various techniques aimed at re-establishing the structural and functional integrity of the affected tissues, thereby promoting the healing process and facilitating a return to normal activities.

Some of the key secondary sources referred to:

  • US Food & Drug Administration (US FDA)
  • Centers for Disease Control and Prevention (CDC)
  • American Academy of Orthopedic Surgeons (AAOS)
  • Association of Surgeons of Great Britain (ASGB)
  • German Society of Surgery (DGCH)
  • European Surgical Association (ESA)
  • The Association of Surgeons of India (ASI)
  • Chinese Society of Laparo-endoscopic Surgery (CSLES)
  • Japan Surgical Society (JSS)
  • Adhesive and Sealants Industry (ASI)
  • General Surgeons Australia (GSA)
  • Brazilian Society of Surgical Oncology (BSSO)
  • American Urological Association (AUA)
  • American Association of Oral and Maxillofacial Surgeons (AAOMS)
  • World Health Organization (WHO)
  • Organization for Economic Co-operation and Development (OECD)
  • Annual Reports, SEC Filings, Investor Presentations, and Press Releases of Key Players
  • White Papers, Journals/Magazines, and News Articles
  • Paid Databases: Factiva, D&B, and Bloomberg Business

Report Objectives

  • To define, describe, and forecast the soft tissue repair market by product, application, end user, and region
  • To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall soft tissue repair market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the revenue of the market segments concerning six main regions: North America (the US and Canada), Europe (Germany, France, the UK, Italy, Spain, and the Rest of Europe), the Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), Latin America (Mexico, Brazil, and the Rest of Latin America), the Middle East & Africa, and GCC Countries
  • To profile the key players in the soft tissue repair market and comprehensively analyze their global revenue shares and core competencies
  • To benchmark players within the market using a proprietary Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy excellence and strength of product portfolio
  • To track and analyze competitive developments, such as product launches & approvals, partnerships, agreements, collaborations, and acquisitions, in the soft tissue repair market

 

Previous Versions of this Report

Soft Tissue Repair Market by Product (Mesh/Tissue patch, Allograft, Xenograft, Suture Anchor, Interference Screws, Laparoscopic Instruments), Application (Hernia, Dural, Orthopedic, Skin, Dental, Vaginal, Breast augmentation) - Global Forecast to 2027

Report Code MD 3215
Published in Mar, 2022, By MarketsandMarkets™

Soft Tissue Repair Market by Product (Mesh/Tissue patch, Allograft, Xenograft, Suture Anchor, Interference Screws, Laparoscopic Instruments), Application (Hernia, Dural, Orthopedic, Skin, Dental, Vaginal, Breast augmentation) - Global Forecast to 2027

Report Code MD 3215
Published in Mar, 2015, By MarketsandMarkets™
"Our USP is "providing game-changing business opportunities reports with free customization" - so please feel free to provide us with your specific areas of interest / business challenges in much greater detail !!"

We appreciate your interest in this report. Once you fill out the form, you'll be immediately directed to an exclusive solution tailored to your needs. This high-value offering can help boost your revenue by 30% - a must-see opportunity for anyone looking to maximize growth.


By clicking the "Submit" button, you are agreeing to the Terms of Use and Privacy Policy.

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Soft Tissue Repair Market

John

May, 2022

Which are the key factors driving the growth of the Global Soft Tissue Repair market?.

Jackson

May, 2022

Which segment, based on product type, accounted for the highest demand in Soft Tissue Repair Market?.

Kahlill

May, 2022

What are the key factors hampering the growth of the Soft Tissue Repair Market?.

DMCA.com Protection Status